Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. (CASE:RMDA) announces a share repurchase program. Under the program, the company will repurchase up to 10% of its issued share capital.
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.
Equities
RMDA
EGS381B1C015
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.99 EGP | 0.00% | -4.78% | +20.61% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+20.61% | 63.31M | |
+31.93% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+15.60% | 239B | |
+10.11% | 210B | |
-7.08% | 200B | |
+8.12% | 167B | |
-1.42% | 161B |
- Stock Market
- Equities
- RMDA Stock
- News Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.
- Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. announces an Equity Buyback for 10% of its issued share capital.